StreetInsider.com News Articles

Form 4 Bluejay Diagnostics, For: Aug 17 Filed by: ZEIDMAN FRED S

Tue, 18 Aug 2026 16:17:00 -0400

si-local-file:///var/storage/secattach/20260818/26944495.html

Form 4 Bluejay Diagnostics, For: Aug 17 Filed by: ZEIDMAN FRED S

Tue, 18 Aug 2026 16:17:00 -0400

si-local-file:///var/storage/secattach/20260818/26944495.html

Form 4 Bluejay Diagnostics, For: Aug 17 Filed by: CHASE DONALD R

Tue, 18 Aug 2026 16:16:00 -0400

si-local-file:///var/storage/secattach/20260818/26944454.html

Form 4 Bluejay Diagnostics, For: Aug 17 Filed by: CHASE DONALD R

Tue, 18 Aug 2026 16:16:00 -0400

si-local-file:///var/storage/secattach/20260818/26944454.html

Form 4 Bluejay Diagnostics, For: Aug 17 Filed by: Dey Svetlana

Tue, 18 Aug 2026 16:16:00 -0400

si-local-file:///var/storage/secattach/20260818/26944466.html

Form 4 Bluejay Diagnostics, For: Aug 17 Filed by: Dey Svetlana

Tue, 18 Aug 2026 16:16:00 -0400

si-local-file:///var/storage/secattach/20260818/26944466.html

Form 4 Bluejay Diagnostics, For: Aug 17 Filed by: Dey Indranil

Tue, 18 Aug 2026 16:16:00 -0400

si-local-file:///var/storage/secattach/20260818/26944467.html

Form 4 Bluejay Diagnostics, For: Aug 17 Filed by: Dey Indranil

Tue, 18 Aug 2026 16:16:00 -0400

si-local-file:///var/storage/secattach/20260818/26944467.html

Form 4 Bluejay Diagnostics, For: Aug 17 Filed by: Wurth Douglas Clark

Tue, 18 Aug 2026 16:16:00 -0400

si-local-file:///var/storage/secattach/20260818/26944487.html

Form 4 Bluejay Diagnostics, For: Aug 17 Filed by: Wurth Douglas Clark

Tue, 18 Aug 2026 16:16:00 -0400

si-local-file:///var/storage/secattach/20260818/26944487.html

Form SCHEDULE 13G Bluejay Diagnostics, Filed by: ARMISTICE CAPITAL, LLC

Fri, 14 Aug 2026 10:04:00 -0400

si-local-file:///var/storage/secattach/20260814/26926104.html

Form SCHEDULE 13G Bluejay Diagnostics, Filed by: ARMISTICE CAPITAL, LLC

Fri, 14 Aug 2026 10:04:00 -0400

si-local-file:///var/storage/secattach/20260814/26926104.html

Form SCHEDULE 13G Bluejay Diagnostics, Filed by: Ayrton Capital LLC

Thu, 13 Aug 2026 12:27:00 -0400

si-local-file:///var/storage/secattach/20260813/26919086.html

Form SCHEDULE 13G Bluejay Diagnostics, Filed by: Ayrton Capital LLC

Thu, 13 Aug 2026 12:27:00 -0400

si-local-file:///var/storage/secattach/20260813/26919086.html

Form 8-K Bluejay Diagnostics, For: Aug 13

Thu, 13 Aug 2026 07:56:00 -0400

si-local-file:///var/storage/secattach/20260813/26916654.html

Form 8-K Bluejay Diagnostics, For: Aug 13

Thu, 13 Aug 2026 07:56:00 -0400

si-local-file:///var/storage/secattach/20260813/26916654.html

Bluejay Diagnostics completes enrollment in IL-6 pivotal study

Thu, 13 Aug 2026 06:01:06 -0400

Bluejay Diagnostics, Inc. (NASDAQ: BJDX) reported its second-quarter 2026 financial results, disclosing that its SYMON-II pivotal clinical study has completed targeted enrollment of 750 hospital patients, according to a press release from the Acton, Mass.-based company.

The company said it is progressing toward analytical and clinical validation activities intended to support a future FDA 510(k) submission for its Symphony IL-6 test, a rapid diagnostic tool for sepsis triage. Bluejay also signed a U.S. manufacturing contract, which the company said is intended to mitigate supply-chain risk ahead of a planned commercialization effort.

At June 30, 2026, Bluejay held approximately $9.6 million in cash

Bluejay Diagnostics Reports Q2 2026 Results; Strengthened Balance Sheet Supports Advancement of Symphony™ IL-6 Toward Regulatory Submission and Commercialization

Thu, 13 Aug 2026 06:00:00 -0400

SYMON-II pivotal clinical study completes targeted enrollment of 750 patients
Company advances toward planned 510(k) submission and commercialization with US manufacturing contract signed to mitigate supply-chain risk
Company ends second quarter with approximately $9.6 million in cash following significant financing

ACTON, Mass., Aug. 13, 2026 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical diagnostics company focused on improving patient outcomes in critical care settings, today reported financial results for the quarter ended June 30, 2026 and provided an update on the Company’s clinical, regulatory and manufacturing progress.

During

Bluejay Diagnostics Reports Q2 2026 Results; Strengthened Balance Sheet Supports Advancement of Symphony™ IL-6 Toward Regulatory Submission and Commercialization

Thu, 13 Aug 2026 06:00:00 -0400

SYMON-II pivotal clinical study completes targeted enrollment of 750 patients
Company advances toward planned 510(k) submission and commercialization with US manufacturing contract signed to mitigate supply-chain risk
Company ends second quarter with approximately $9.6 million in cash following significant financing

During

Bluejay Diagnostics Reports Q2 2026 Results; Strengthened Balance Sheet Supports Advancement of Symphony™ IL-6 Toward Regulatory Submission and Commercialization

Thu, 13 Aug 2026 06:00:00 -0400

SYMON-II pivotal clinical study completes targeted enrollment of 750 patients
Company advances toward planned 510(k) submission and commercialization with US manufacturing contract signed to mitigate supply-chain risk
Company ends second quarter with approximately $9.6 million in cash following significant financing

During

Bluejay Diagnostics Reports Q2 2026 Results; Strengthened Balance Sheet Supports Advancement of Symphony™ IL-6 Toward Regulatory Submission and Commercialization

Thu, 13 Aug 2026 06:00:00 -0400

SYMON-II pivotal clinical study completes targeted enrollment of 750 patients
Company advances toward planned 510(k) submission and commercialization with US manufacturing contract signed to mitigate supply-chain risk
Company ends second quarter with approximately $9.6 million in cash following significant financing

During

Form S-8 Bluejay Diagnostics,

Wed, 12 Aug 2026 16:42:00 -0400

si-local-file:///var/storage/secattach/20260812/26913708.html

Form S-8 Bluejay Diagnostics,

Wed, 12 Aug 2026 16:42:00 -0400

si-local-file:///var/storage/secattach/20260812/26913708.html

Form 10-Q Bluejay Diagnostics, For: Jun 30

Wed, 12 Aug 2026 16:07:00 -0400

si-local-file:///var/storage/secattach/20260812/26912808.html

Form 10-Q Bluejay Diagnostics, For: Jun 30

Wed, 12 Aug 2026 16:07:00 -0400

si-local-file:///var/storage/secattach/20260812/26912808.html